Joseph Hulihan

3.1k total citations
39 papers, 2.1k citations indexed

About

Joseph Hulihan is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Pathology and Forensic Medicine. According to data from OpenAlex, Joseph Hulihan has authored 39 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Psychiatry and Mental health, 12 papers in Pediatrics, Perinatology and Child Health and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Joseph Hulihan's work include Epilepsy research and treatment (17 papers), Migraine and Headache Studies (14 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Joseph Hulihan is often cited by papers focused on Epilepsy research and treatment (17 papers), Migraine and Headache Studies (14 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Joseph Hulihan collaborates with scholars based in United States, Germany and France. Joseph Hulihan's co-authors include Steven J. Greenberg, David W. Dodick, Rodger J. Elble, William G. Ondo, Mark Stacy, Shu‐Chen Wu, Steven Ascher, Ninan T. Mathew, Stephen D. Silberstein and Donna Jordan and has published in prestigious journals such as Neurology, Epilepsia and Movement Disorders.

In The Last Decade

Joseph Hulihan

39 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Hulihan United States 23 1.6k 672 561 493 408 39 2.1k
Laurence Watkins United Kingdom 30 690 0.4× 548 0.8× 1.6k 2.9× 427 0.9× 1.2k 3.0× 120 2.8k
Derya Uludüz Türkiye 22 1.6k 1.0× 792 1.2× 275 0.5× 434 0.9× 121 0.3× 83 2.0k
David M. Biondi United States 25 1.5k 1.0× 1.1k 1.6× 252 0.4× 802 1.6× 86 0.2× 61 2.2k
Katarina Laurell Sweden 26 463 0.3× 343 0.5× 890 1.6× 181 0.4× 1.1k 2.7× 61 1.9k
Amy Goodman United States 12 815 0.5× 323 0.5× 534 1.0× 247 0.5× 78 0.2× 34 1.5k
Gennaro Bussone Italy 23 1.3k 0.8× 887 1.3× 297 0.5× 541 1.1× 82 0.2× 113 1.8k
Jiing-Feng Lirng Taiwan 26 662 0.4× 256 0.4× 624 1.1× 169 0.3× 206 0.5× 90 1.9k
Todd D. Rozen United States 26 1.9k 1.2× 1.3k 1.9× 547 1.0× 913 1.9× 92 0.2× 124 2.4k
Rigmor Jensen Denmark 10 1.7k 1.1× 851 1.3× 212 0.4× 748 1.5× 39 0.1× 13 2.0k
Mehmet Zarifoğlu Türkiye 21 788 0.5× 425 0.6× 237 0.4× 281 0.6× 72 0.2× 55 1.2k

Countries citing papers authored by Joseph Hulihan

Since Specialization
Citations

This map shows the geographic impact of Joseph Hulihan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Hulihan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Hulihan more than expected).

Fields of papers citing papers by Joseph Hulihan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Hulihan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Hulihan. The network helps show where Joseph Hulihan may publish in the future.

Co-authorship network of co-authors of Joseph Hulihan

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Hulihan. A scholar is included among the top collaborators of Joseph Hulihan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Hulihan. Joseph Hulihan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olson, Heather E., Sam Amin, Nadia Bahi‐Buisson, et al.. (2023). Long‐term treatment with ganaxolone for seizures associated with cyclin‐dependent kinase‐like 5 deficiency disorder: Two‐year open‐label extension follow‐up. Epilepsia. 65(1). 37–45. 16 indexed citations
2.
Singh, Rani K., et al.. (2022). Intravenous ganaxolone in pediatric super-refractory status epilepticus: A single hospital experience. Epilepsy & Behavior Reports. 20. 100567–100567. 6 indexed citations
3.
4.
Guterman, Elan L., John P. Betjemann, Alex A. Aimetti, et al.. (2021). Association Between Treatment Progression, Disease Refractoriness, and Burden of Illness Among Hospitalized Patients With Status Epilepticus. JAMA Neurology. 78(5). 588–588. 44 indexed citations
5.
Scheffer, Ingrid E., Joseph Hulihan, John A. Messenheimer, et al.. (2020). Cannabidiol Transdermal Gel in Children and Adolescents with Developmental and Epileptic Encephalopathies: An Open-label Clinical Trial (1631). Neurology. 94(15_supplement). 1 indexed citations
6.
7.
Loring, David W., et al.. (2010). Topiramate dose effects on cognition. Neurology. 76(2). 131–137. 80 indexed citations
8.
Cady, Roger, Frederick G. Freitag, Ninan T. Mathew, et al.. (2009). Allodynia‐Associated Symptoms, Pain Intensity and Time to Treatment: Predicting Treatment Response in Acute Migraine Intervention. Headache The Journal of Head and Face Pain. 49(3). 350–363. 23 indexed citations
9.
Silberstein, Stephen D., Richard B. Lipton, David W. Dodick, et al.. (2009). Topiramate Treatment of Chronic Migraine: A Randomized, Placebo‐Controlled Trial of Quality of Life and Other Efficacy Measures. Headache The Journal of Head and Face Pain. 49(8). 1153–1162. 100 indexed citations
10.
Adelman, James U., Fred Freitag, Miguel J. A. Láinez, et al.. (2008). Analysis of Safety and Tolerability Data Obtained from Over 1,500 Patients Receiving Topiramate for Migraine Prevention in Controlled Trials. Pain Medicine. 9(2). 175–185. 40 indexed citations
11.
Silberstein, Stephen D., Hans‐Christoph Diener, Richard B. Lipton, et al.. (2008). Epidemiology, Risk Factors, and Treatment of Chronic Migraine: A Focus on Topiramate. Headache The Journal of Head and Face Pain. 48(7). 1087–1095. 32 indexed citations
12.
Stacy, Mark, et al.. (2007). Assessment of interrater and intrarater reliability of the Fahn–Tolosa–Marin Tremor Rating Scale in essential tremor. Movement Disorders. 22(6). 833–838. 229 indexed citations
13.
Freitag, Frederick G., Gary Finlayson, Alan M. Rapoport, et al.. (2007). Effect of Pain Intensity and Time to Administration on Responsiveness to Almotriptan: Results from AXERT ® 12.5 mg Time Versus Intensity Migraine Study (AIMS). Headache The Journal of Head and Face Pain. 47(4). 519–530. 35 indexed citations
14.
15.
Ondo, William G., Joseph Jankovic, Gregory S. Connor, et al.. (2006). Topiramate in essential tremor. Neurology. 66(5). 672–677. 114 indexed citations
16.
Winner, Paul, et al.. (2005). Topiramate for Migraine Prevention in Children: A Randomized, Double‐Blind, Placebo‐Controlled Trial. Headache The Journal of Head and Face Pain. 45(10). 1304–1312. 135 indexed citations
17.
Hulihan, Joseph. (1997). Seizures in special populations. Postgraduate Medicine. 102(1). 165–178. 2 indexed citations
18.
Harada, Russell N., et al.. (1995). Stump pressure, electroencephalographic changes, and the contralateral carotid artery: Another look at selective shunting. The American Journal of Surgery. 170(2). 148–153. 52 indexed citations
19.
Cascino, Gregory D., Joseph Hulihan, Frank W. Sharbrough, & Patrick J. Kelly. (1993). Parietal Lobe Lesional Epilepsy: Electroclinical Correlation and Operative Outcome. Epilepsia. 34(3). 522–527. 62 indexed citations
20.
Cascino, Gregory D., Patrick J. Kelly, Frank W. Sharbrough, et al.. (1992). Long‐Term Follow‐Up of Stereotactic Lesionectomy in Partial Epilepsy: Predictive Factors and Electroencephalographic Results. Epilepsia. 33(4). 639–644. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurence Watkins Breakdown of academic impact, for papers by Derya Uludüz Breakdown of academic impact, for papers by David M. Biondi Breakdown of academic impact, for papers by Katarina Laurell Breakdown of academic impact, for papers by Amy Goodman Breakdown of academic impact, for papers by Gennaro Bussone Breakdown of academic impact, for papers by Jiing-Feng Lirng Breakdown of academic impact, for papers by Todd D. Rozen Breakdown of academic impact, for papers by Rigmor Jensen Breakdown of academic impact, for papers by Mehmet Zarifoğlu
Rankless by CCL
2026